A report by the HHS Office of Inspector General has identified states that saved millions by using rebates on blood glucose test strips and highlighted possible savings for state Medicaid agencies from competitive bidding for such supplies. The OIG also recommended collaboration between the CMS and state Medicaid agencies to see whether manufacturer rebates and lower provider reimbursement rates may lead to savings.

Related Summaries